F nucleatum activates NF-κB, ERK, and AKT pathways in colon cancer cells via TLR4 receptors, increasing inflammatory factors and metabolites and driving tumor progression.[6,16,17] Lipopolysaccharides are essential components of the outer membrane of Gram-negative bacteria. Here, NFKB1 is linked to neoplasm.